Manish Jotwani, MD
Nephrology · Flushing, NYNPI 1942277173
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (59.2%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by AV Medical Technologies Ltd. at 59.2% of the total. Reporting peaked in 2019 at $33,349 and has fallen 98.9% since, to $365 in 2025. Among nephrology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 38 payments — averaging $910.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AV Medical Technologies Ltd.$21K
- Medtronic$13K
- Bard Peripheral Vascular, Inc.$433
- Otsuka America Pharmaceutical, Inc.$168
- Amarin Pharma, Inc.$125
- Lemaitre Vascular, Inc.$31
- plus $45 from 3 others
What the payments were for
- Royalty or licence$12,49736%
- Consulting fees$20,50059%
- Food & beverage$1,6065%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AV Medical Technologies Ltd. | 2 | $20,500 |
| Medtronic(2 entities) | 18 | $13,301 |
| Bard Peripheral Vascular, Inc. | 9 | $433 |
| Otsuka America Pharmaceutical, Inc. | 4 | $168 |
| Amarin Pharma, Inc. | 1 | $125 |
| Lemaitre Vascular, Inc. | 1 | $31 |
| Covidien LP | 1 | $22 |
| Novo Nordisk | 1 | $17 |
| Avenu Medical Inc. | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$34,603 in reported general payments places this provider in the 90th percentile of 935 nephrology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 36 | $164 |
Paid to pharmacies, not to this prescriber.
Other nephrology in Flushing
- Elizabeth LiangFlushing$53K
- Payam ShakouriPoughkeepsie$930K
- Gerald AppelNew York$842K
- Richard ChanNew York$514K
- Bruce SpinowitzBronx$465K
- Steven CocaNew York$445K
- Joseph RoglieriTroy$425K
- Jai RadhakrishnanNew York$369K
- Savneek ChughHawthorne$325K
- Gerard TepedinoManhasset$308K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.